Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Yarden

Showing results (1-10 of 166) with videos related to

Pageof 17
Sort By:
Breast Disease|February 3, 2005
Breast disease. IntroductionY Yarden
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1990
Agonistic antibodies stimulate the kinase encoded by the neu protooncogene in living cells but the oncogenic mutant is constitutively activeY Yarden
European Journal of Cancer (Oxford, England : 1990)|October 13, 2001
The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunitiesY Yarden
Oncology|November 6, 2001
Biology of HER2 and its importance in breast cancerY Yarden
Molecular Immunology|December 1, 1990
Receptor-like oncogenes: functional analysis through novel experimental approachesY Yarden
Annual Review of Biochemistry|January 1, 1988
Growth factor receptor tyrosine kinasesY Yarden, A Ullrich
Neuron|June 1, 1997
Neuregulins and their receptors: a versatile signaling module in organogenesis and oncogenesisS Burden, Y Yarden
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2001
The basic biology of HER2I Rubin, Y Yarden
FEBS Letters|February 27, 2001
Molecular mechanisms underlying endocytosis and sorting of ErbB receptor tyrosine kinasesH Waterman, Y Yarden
Biochemistry|April 9, 1991
Biochemical analysis of the ligand for the neu oncogenic receptorY Yarden, E Peles
Pageof 17

Showing results (1-10 of 166) with videos related to

Sort By:
Pageof 17
Breast Disease|February 3, 2005
Breast disease. IntroductionY Yarden
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1990
Agonistic antibodies stimulate the kinase encoded by the neu protooncogene in living cells but the oncogenic mutant is constitutively activeY Yarden
European Journal of Cancer (Oxford, England : 1990)|October 13, 2001
The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunitiesY Yarden
Oncology|November 6, 2001
Biology of HER2 and its importance in breast cancerY Yarden
Molecular Immunology|December 1, 1990
Receptor-like oncogenes: functional analysis through novel experimental approachesY Yarden
Annual Review of Biochemistry|January 1, 1988
Growth factor receptor tyrosine kinasesY Yarden, A Ullrich
Neuron|June 1, 1997
Neuregulins and their receptors: a versatile signaling module in organogenesis and oncogenesisS Burden, Y Yarden
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2001
The basic biology of HER2I Rubin, Y Yarden
FEBS Letters|February 27, 2001
Molecular mechanisms underlying endocytosis and sorting of ErbB receptor tyrosine kinasesH Waterman, Y Yarden
Biochemistry|April 9, 1991
Biochemical analysis of the ligand for the neu oncogenic receptorY Yarden, E Peles
Pageof 17